Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on pediatric acute lymphoblastic leukemia (ALL) with respect to Bcr-Abl status and imatinib mesylate sensitivity. [electronic resource]
Producer: 20050916Description: 430-7 p. digitalISSN:- 0031-3998
- Adult
- Anti-Bacterial Agents -- metabolism
- Antineoplastic Agents -- metabolism
- Apoptosis -- drug effects
- Benzamides
- Benzoquinones
- Cell Line, Tumor
- Cell Survival -- drug effects
- Child
- Drug Resistance, Neoplasm
- Drug Therapy, Combination
- Genes, abl
- Humans
- Imatinib Mesylate
- Lactams, Macrocyclic
- Piperazines -- metabolism
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Protein Kinase Inhibitors -- metabolism
- Pyrimidines -- metabolism
- Rifabutin -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.